Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $56.60 ($2.3M) on 2018-09-07, disclosed to the SEC on 2018-09-07.
Scheduled sale ($2.3M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.66 | 718 | $41K | 1.8% |
| 2 | $57.73 | 12,480 | $720K | 31.6% |
| 3 | $58.85 | 2,820 | $166K | 7.3% |
| 4 | $59.08 | 200 | $12K | 0.5% |
| 5 | $59.77 | 3,600 | $215K | 9.4% |
| 6 | $56.58 | 718 |
| $41K |
| 1.8% |
| 7 | $56.60 | 15,495 | $877K | 38.5% |
| 8 | $57.30 | 200 | $11K | 0.5% |
| 9 | $57.44 | 3,405 | $196K | 8.6% |
| Total | $57.51 avg | 39,636 | $2.3M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |